Because studies show the medication is a large molecule, it may not transfer much, but without research, experts advise against using it while breastfeeding
The risk intensifies in the first 48 weeks of therapy when your body is still adjusting to semaglutide's effects
In metabolic research, common readouts include body mass change, food intake, circulating biomarkers, adipose depot measurements, and indirect markers of substrate handling and energy use
This is how we deliver on our promise to put patients first - by making innovative medicines more accessible, at a lower cost, while providing patients and physicians choices in this fast-evolving market. Evernorth has the most extensive suite of GLP-1 solutions available with this new addition, which also includes: EncircleRx, a financial model with more than 9 million enrolled lives that has saved health plans $200 million dollars since 2024